A new powerful drug to combat river blindness
نویسندگان
چکیده
منابع مشابه
A new powerful drug to combat river blindness
www.thelancet.com Published online January 17, 2018 http://dx.doi.org/10.1016/S0140-6736(18)30101-6 1 Onchocerciasis, which is a disease caused by the filarial worm Onchocerca volvulus, is transmitted from individual to individual by Simulium black flies that breed in fast flowing rivers. The millions of larvae (microfilariae) released by the adult parasites invade skin and eyes where they can ...
متن کاملRotavirus vaccine--a powerful tool to combat deaths from diarrhea.
Rotavirus infection, the leading cause of severe childhood diarrhea in both developed and developing countries, results in over half a million deaths each year.1 Currently, two rotavirus vaccines (Rotarix [GlaxoSmithKline Biologicals] and RotaTeq [Merck]) are licensed in many countries and used routinely in several. Until recently, available efficacy data were from developed and developing coun...
متن کاملOnchocerciasis--river blindness.
Onchocerciasis results from infestation by the nematode Onchocerca volvulus and is characterized by troublesome itching, skin lesions, and eye manifestations. Although partially controlled by international mass prevention programs, onchocerciasis remains a major health hazard and is endemic in Africa, Arabia, and the Americas. Onchocerciasis is spread by bites from infested black flies, which t...
متن کاملRiver Blindness: A Success Story under Threat?
he accomplishments of this Programme inspire all of us in public health to dream big dreams. It shows we can reach 'impossible' goals and lighten the burden of millions of the world's poorest people .... " These were the concluding words by former World Health Organization Director-General Gro Harlem Brundtland at the closure ceremony of the Onchocerciasis Control Programme in West Africa (OCP)...
متن کاملTherapeutic nanoparticles to combat cancer drug resistance.
This review focuses on the application of drug-loaded nanoparticles (NPs), also called therapeutic NPs, to combat cancer chemoresistance. Many cancer patients have encouraging response to first line chemotherapies but end up with cancer progression or cancer recurrence that requires further treatment. Response to subsequent chemotherapies with various agents usually drops significantly due to f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 2018
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(18)30101-6